{"filing":{"accession_number":"0001937653-26-000046","cik":"0001937653","ticker":"ZYME","company_name":"Zymeworks Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"zyme-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1937653/000193765326000046/zyme-20260806.htm"},"events":[{"id":26013,"run_id":23623,"accession_number":"0001937653-26-000046","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Zymeworks issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing Q2 2026 revenue of $4.6 million, net loss of $45.0 million, R\u0026D expenses of $27.4 million, and G\u0026A expenses of $19.3 million, along with corporate updates and strategic highlights.","company_name":"Zymeworks Inc.","ticker":"ZYME","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26989,"accession_number":"0001937653-26-000046","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zymeworks issued a press release on August 6, 2026 announcing its financial results for the three months ended June 30, 2026, disclosing Q2 2026 revenue of $4.6 million, net loss of $45.0 million, R\u0026D expenses of $27.4 million, and G\u0026A expenses of $19.3 million. This is a standard quarterly earnings release attached as Exhibit 99.1 to the 8-K Item 2.02 filing, disclosing material financial performance metrics that would affect investor assessment of the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:27.681201+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26990,"accession_number":"0001937653-26-000046","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure is accompanied by EX-99.1, a formal earnings release dated August 6, 2026, titled \"Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results.\" The release presents Q2 2026 financial results (revenue of $4.6 million, net loss of $45.0 million), comparative prior-year figures, and detailed business highlights including regulatory milestones and strategic initiatives. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:27.681201+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26989,"accession_number":"0001937653-26-000046","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zymeworks issued a press release on August 6, 2026 announcing its financial results for the three months ended June 30, 2026, disclosing Q2 2026 revenue of $4.6 million, net loss of $45.0 million, R\u0026D expenses of $27.4 million, and G\u0026A expenses of $19.3 million. This is a standard quarterly earnings release attached as Exhibit 99.1 to the 8-K Item 2.02 filing, disclosing material financial performance metrics that would affect investor assessment of the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:27.681201+00:00","company_name":"Zymeworks Inc.","ticker":"ZYME","filing_date":"2026-08-06"},{"id":26990,"accession_number":"0001937653-26-000046","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure is accompanied by EX-99.1, a formal earnings release dated August 6, 2026, titled \"Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results.\" The release presents Q2 2026 financial results (revenue of $4.6 million, net loss of $45.0 million), comparative prior-year figures, and detailed business highlights including regulatory milestones and strategic initiatives. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:27.681201+00:00","company_name":"Zymeworks Inc.","ticker":"ZYME","filing_date":"2026-08-06"}]}